Caterpillar's Earnings Reflect Slower Emerging Markets Trend

Michael Teague |

Global construction machinery giant Caterpillar (CAT) was down on Wednesday as the company’s earnings report reflected a slump in sales resulting from a slowdown in the mining sector and lower growth from emerging markets in general, falling far short of expectations.

For the second quarter, Caterpillar netted $960 million, or $1.45 per share on revenue of $14.6 billion, compared to the prior year period during which the company made $1.70 billion, or $2.54 per share on revenue of $17.4 billion. Analysts had expected a significantly larger earnings-per-share figure of $1.70, and revenue of $14.9 billion.

Furthermore, while analysts had expected a full-year 2013 profit of $6.81 per share on sales of $58.6 billion, the company cut its forecast for 2013, saying it expects to earn $6.50 per share on earnings of between $56 and $58 billion. Caterpillar grossed $65.9 billion in 2012. The company had previously already cut its forecast after the first quarter’s disappointing earnings report.

Sales figures were the most disappointing in the Asia-Pacific region, down 25 percent on the prior year period, with mining companies cutting spending in Australia, the world’s biggest exporter of iron ore and coal, and unexpectedly slow growth out of China that has put a hold on construction projects.  Sales were also down 14 percent for Latin America, and 9 percent in North America.

Last week, mining industry leaders Rio Tinto Plc ($RIO) and BHP Billiton Plc ($BBL) watched their stocks jump after both released impressive earnings reports that saw an increase in the production and sale of both iron ore and copper. But both companies have also been cutting costs and scaling back operations, part of a larger recent phenomenon within the industry as growth out of emerging markets puts on the breaks. Barrick Gold Corp. (ABX) and Freeport McMoran Copper & Gold Inc. (FCX) , respectively the largest gold and copper miners, have both canceled projects and cut capital spending as well, and Caterpillar is feeling the hurt from these contractions.

Last week also saw legendary short-seller Jim Chanos telling investors that they should short the company. The move made headlines but was not surprising from a fundamental standpoint, as this is Caterpillar’s third consecutive ugly earnings report, and the economic crunch in emerging markets has hurt the mining industry into which the company has invested a great deal over the past few years.

Despite the bad news, chairman and CEO Doug Oberhelman, remained positive, and while admitting to CNBC that there is “no question there’s a slowdown,” and going on to say that over the longer-term, mining is good place for the company to be. Shares were off 3.15 percent to $82.83 in midday trading. Caterpillar is 3.3 percent in 2013, but has declined more than 11 percent in the last six months.

[Image: A Caterpillar tractor on site in Nancy, France 2010. Courtesy of Fotopedia]

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Symbol Name Price Change % Volume
ABX Barrick Gold Corporation 16.92 -0.12 -0.70 8,518,578
BBL BHP Billiton plc Sponsored ADR 30.15 -0.10 -0.33 1,851,320
CAT Caterpillar Inc. 86.33 -0.30 -0.35 3,592,524
CWLDY Crown Resorts Ltd. ADR 17.47 0.00 0.00 18
FCX Freeport-McMoRan Inc. 10.04 -0.17 -1.67 20,960,781
RIO Rio Tinto Plc 32.87 0.45 1.39 3,523,873


Emerging Growth

Breathtec BioMedical Inc.

Breathtec Biomedical Inc is a medical diagnostics company. It is engaged in developing & commercializing breath analysis devices for the early detection of infections & life threatening diseases including cancers,…

Private Markets

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…

MyForce, Inc.

As parents, we constantly worry about the safety of our loved ones. The media bombards us with incidents from across the nation school shootings, frequent assaults on campuses, and crimes…